Home Compare BSX vs PODD
Stock Comparison · Industry comparison · Medical Devices

Boston Scientific vs Insulet: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Boston Scientific carrying a narrow edge on stability. Insulet still has the edge on profitability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest score difference appears in stability, while profitability still leans the other way.

INDUSTRY COMPARISON

Both operate in: Medical Devices

This comparison is based on industry proximity, not on functional trajectory similarity. BSX and PODD share the same industry classification.

For a similarity-based comparison, see how Boston Scientific and Insulet each position within their functional peer groups in AssetNext.

Peer-Relative Score
BSX
Boston Scientific Corporation
55
Peer-Score
Signal qualityHigh
vs
PODD
Insulet Corporation
50
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BSX vs PODD Profitability 37 73 Stability 59 18 Valuation 52 29 Growth 83 78 BSX PODD
Gap Ranking
#1 Stability +41
#2 Profitability +36
#3 Valuation +23
#4 Growth +5
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BSX and PODD Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BSXPODD Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against Insulet Corporation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
On stability, Boston Scientific Corporation is positioned higher in the group, while Insulet Corporation is closer to the middle.
Profitability
On profitability, Insulet Corporation ranks near the top of the group; Boston Scientific Corporation sits in the weaker half.
Stability — Dominant Gap
BSX
59
PODD
18
Gap+41in favour of BSX

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

Capital efficiency also runs the other way, with a 6.8-point ROIC edge acting as a real counterforce.

What this means for the comparison

The page question resolves through stability, but profitability and current pricing still keep the broader comparison from reading as fully aligned.

Explore full peer positioning in AssetNext

Break down the BSX vs PODD comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BSX and PODD each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.